在与精神兴奋剂复合体中,本源的血清素载体的结构和膜相互作用
Dongxue Yang1, Zhiyu Zhao2, Emad Tajkhorshid2
1Vollum Institute, Oregon Health and Science University, Portland, OR 97239.
概括
胺转运体 (SERT) 是单质的,与胆固醇相互作用,而不是其他蛋白质. 可卡因和甲基胺结合SERT,使其稳定在一个向外开放的形状,揭示精神兴奋剂结合点.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- 血清载体 (SERT) 调节血清水平,是抗抑郁药和精神刺激药的目标.
- 尽管如此,SERT的关键功能方面,包括它的寡合化和蛋白质相互作用,仍然不清楚.
研究的目的:
- 调查原生SERT的寡合化状态和蛋白质相互作用.
- 确定精神兴奋剂与SERT结合的结构基础.
主要方法:
- 使用温和洗剂将猪大脑SERT (pSERT) 分离.
- 光检测尺寸排除色谱用于寡合化和相互作用研究.
- 单粒子冷电子显微镜用于pSERT-精神兴奋剂复合物的结构阐明.
主要成果:
- 在隔离条件下,pSERT存在于单体形式,不与其他蛋白质相互作用.
- 胆固醇或胆固醇半酸盐 (CHS) 分子和洗剂分子结合到pSERT上的一个全位.
- 甲基胺和可卡因与psert的中心部位结合,稳定了向外开放的形状.
结论:
- 原生SERT主要是单体的,与胆固醇等脂质相互作用.
- 对精神兴奋剂结合的结构洞察力揭示了保存的结合口袋和输送器形状.
- 这些发现提升了对SERT功能和药物相互作用的理解.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
313
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
313
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
444
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
444


